NCT01219829

Brief Summary

The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2009

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 11, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 13, 2010

Completed
10.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2021

Completed
Last Updated

June 11, 2021

Status Verified

June 1, 2021

Enrollment Period

12.1 years

First QC Date

October 11, 2010

Last Update Submit

June 9, 2021

Conditions

Keywords

Pancreatic intraepithelial neoplasia (PanIN)Pancreatic CancerRecurrence of pancreatic cancerField EffectGenetic mutations in pancreatic cancer

Outcome Measures

Primary Outcomes (1)

  • Number of subjects with histological features of PanIN lesions assessed

    Distinctive histological features of PanIN within surgical specimens of our two study groups will be assessed by pathologists.

    1 year

Secondary Outcomes (2)

  • Evaluation of clonality multifocal PanIN lesions

    1 year

  • Evaluation of Recurrence Mechanism in PDC

    1 year

Study Arms (2)

Family History patients

Patients with a strong family history of pancreatic cancer or with a genetic syndrome that puts them at risk for pancreas cancer.

Recurrence patients

Patients who underwent surgery for pancreatic cancer and developed tumor recurrence after surgery

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are identified by a clinician as having either 1) a strong family history of pancreatic cancer; or 2) evidence (radiological or pathological) of local tumor recurrence following surgical resection, will be included in the study.

You may qualify if:

  • Tissue-confirmed diagnosis of pancreatic adenocarcinoma.
  • Underwent surgical resection for adenocarcinoma at Columbia-Presbyterian Medical Center with pathologically negative surgical margins.
  • Enrolled in our Pancreatic Cancer Registry and Tissue Bank protocol (AAAA-6154).
  • Have at least 2 relatives (of whom one must be first-degree relative) with pancreatic cancer, or have been diagnosed with a a genetic syndrome which is associated with pancreatic cancer (among the included syndromes include BRCA1/2, FAMMM, Peutz-Jeghers, HNPCC, Hereditary Pancreatitis) -OR- Have radiological or pathological (fine needle aspirate or surgical biopsy) evidence of local tumor recurrence following surgery.

You may not qualify if:

  • Metastatic disease discovered at presentation or on recurrence (exception is the familial PDC patients)
  • Positive surgical margins.
  • Lack of clinical followup at one year following surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

* Blood samples * Specimens of tumors, pre-cancerous lesions, and normal tissue from patients who need to have endoscopy or surgery for diagnosis or treatment of tumors that develop * Samples of urine and stool, and duodenal aspirates if an individual will be having an endoscopy

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Wendy K Chung, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2010

First Posted

October 13, 2010

Study Start

March 18, 2009

Primary Completion

April 27, 2021

Study Completion

April 27, 2021

Last Updated

June 11, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations